Mostly Cloudy, 61° F
153 stories tagged ‘Beth Israel Deaconess Medical Center’
Members of the Harvard community responded to the Boston Marathon attacks and offered thoughts about both the physical and mental injuries they caused.
Technology to help monitor concussions
Researchers recently completed the first clinical study of a new rapid neuroassessment device they developed to quantitatively measure neuromuscular performance. The team is currently conducting a study with athletes in the Boston area to determine the sensitivity of the technology in diagnosing concussions.
Doctors can feel their patients’ pain
A novel experiment illuminates the importance of the doctor-patient relationship, providing the first data into the underlying neurobiology of the caregiver.
Noncancerous cells carry weight
In recent years Harvard investigators have discovered that breast tumors are influenced by more than just the cancer cells within them.
Fat fighters found in fat tissue
Researchers at Harvard Medical School and Harvard-affiliated Beth Israel Deaconess Medical Center have found that a type of immune cell plays a role in guarding against obesity, diabetes, and metabolic disease.
Using nature to inspire robotics
The annual symposium of the Wyss Institute for Biologically Inspired Engineering, held at Harvard Medical School, prompted a spirited discussion on robotics and medicine, with nature as a model.
Bridging the doctor-patient divide
Graduating Harvard Medical School student Katherine Johnson hopes to bridge barriers between doctors and patients by using her skills in the community as she begins her residency.
Flavonoid compound can prevent blood clots
Harvard researchers have shown that a compound called rutin, commonly found in fruits and vegetables and sold over the counter as a dietary supplement, inhibits the formation of blood clots in an animal model of thrombosis.
An opening against Alzheimer’s
Findings by a team at Harvard-affiliated Beth Israel Deaconess Medical Center suggest a new strategy for diagnosing and treating Alzheimer’s disease.
Obesity? Diabetes? We’ve been set up
The twin epidemics of obesity and its cousin, diabetes, have been the target of numerous studies at Harvard and its affiliated hospitals and institutions. Harvard researchers have produced a dizzying array of findings on the often related problems.
As a liberal arts college, Harvard trains its students broadly so they can adapt nimbly to a rapidly changing world. Increasingly, appreciating and participating in music are integral parts of student life.
Exploring roots of hunger, eating behaviors
Synaptic plasticity — the ability of the synaptic connections between the brain’s neurons to change and modify over time — has been shown to be a key to memory formation and the acquisition of new learning behaviors. Now research reveals that the neural circuits controlling hunger and eating behaviors are also controlled by plasticity.
Tumor cells can prevent tumor spread
A new study from Harvard-affiliated Beth Israel Deaconess Medical Center finds that a group of little-explored cells in the tumor microenvironment likely serves as an important gatekeeper against cancer progression and metastasis.
Rebuilding the brain’s circuitry
Harvard scientists have rebuilt genetically diseased circuitry in a section of the mouse hypothalamus, an area controlling obesity and energy balance, demonstrating that complex and intricately wired circuitry of the brain long considered incapable of cellular repair can be rewired with the right type of neuronal “replacement parts.”
Survival strategy of cancer cells
A new study led by a scientific team at Beth Israel Deaconess Medical Center and Harvard Medical School has uncovered another key mechanism that cancer cells use as part of their survival strategy — and once again it seems that they are using an enzyme called PKM2 to their advantage.
In ES 227, "Medical Device Design," SEAS students are given the opportunity to solve practical problems in a hospital setting, trying out the tools, learning about their use in real-world situations, and, in some cases, even sitting in on surgical procedures.
Schermerhorn named distinguished fellow
The Society for Vascular Surgery elected Harvard Medical School professor Marc Schermerhorn as a distinguished fellow.
When the final mission of NASA’s 30-year Space Shuttle program is launched on Friday (July 8), an animal experiment to test a novel therapy to increase bone mass will be on board. Harvard Medical School Asssistant Professor Mary Bouxsein is among the lead researchers.
A duo of drugs, each targeting a prime survival strategy of tumors, can be safely administered and is potentially more effective than either drug alone for advanced, inoperable melanomas, according to a phase 1 clinical trial led by Harvard investigators at the Dana-Farber Cancer Institute.
Harvard Medical School researchers believe that identifying the properties of the herpes viruses found in Africa could open the door to developing a more potent vaccine against an infection now rampant in sub-Saharan Africa.
Robert M. Goldwyn graduated from Harvard Medical School and later returned there and became Senior Surgeon at the Peter Bent Brigham and Beth Israel Hospitals.
Spotlight on Harvard in Brazil
President Drew Faust is traveling this week to highlight Harvard’s engagement with Latin America. In Brazil, she is reconnecting with alumni, exchanging ideas with the leaders of local universities, and meeting with Brazilian students who have studied alongside Harvard students or with Harvard faculty in Brazil.
BIDMC’s Pandolfi to receive cancer research award
Cancer geneticist Pier Paolo Pandolfi at Harvard-affiliated Beth Israel Deaconess Medical Center is the recipient of the 2011 Pezcoller Foundation-AACR International Award for Cancer Research.
Harvard researchers have estimated the likely cost-effectiveness of post-discharge follow-up phone calls to smokers hospitalized with acute heart attacks. In a report in the Archives of Internal Medicine, the researchers suggest that phone calls to these discharged smokers encouraging them to quit would yield significant health and economic gains.
Placebos work — even without deception
Patients who were knowingly given placebos for irritable bowel syndrome experienced significant symptom relief when compared with controls.
Gazette Print Archives
RSS Feed
© 2013 The President and Fellows of Harvard College